Clinical Trials: Lipid Regulating Agents
- Acipimox 11 studies
- Allicin 5 studies
- Amlodipine, atorvastatin drug combination 15 studies
- Anticholesteremic Agents 1230 studies
- Atorvastatin 472 studies
- Benfluorex 1 study
- Betaine 21 studies
- Bezafibrate 5 studies
- Chitosan 18 studies
- Cholestyramine Resin 10 studies
- Choline 71 studies
- Ciprofibrate 2 studies
- Clofibrate 2 studies
- Clofibric Acid 16 studies
- Colesevelam 35 studies
- Colestipol 4 studies
- Dalcetrapib 12 studies
- Efamol 9 studies
- Essential 303 forte 1 study
- Ethionamide 1 study
- Ezetimibe 198 studies
- Fenofibrate 121 studies
- Fenofibric acid 25 studies
- Fluvastatin 49 studies
- Gemfibrozil 14 studies
- Glucuronyl glucosamine glycan sulfate 15 studies
- Hydroxymethylglutaryl-CoA Reductase Inhibitors 1209 studies
- Hypolipidemic Agents 1591 studies
- Isoniazid 80 studies
- Lovastatin 43 studies
- Niacin 199 studies
- Pitavastatin 41 studies
- Policosanol 11 studies
- Polyene phosphatidylcholine 2 studies
- Pravastatin 105 studies
- Probucol 15 studies
- Red yeast rice 18 studies
- Rice bran oil 1 study
- Rosuvastatin 224 studies
- Simvastatin 366 studies
- Sitosterol 4 studies
- Sucrose polyester 3 studies
- Torcetrapib 15 studies
- Triclosan 43 studies
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://www.clinicaltrialsfeeds.org/clinical-trials/browse/intr_cat_Lipd
